References
- Esserman LJ, Shieh Y, Rutgers EJ, . Impact of mammographic screening on the detection of good and poor prognosis breast cancers. Breast Cancer Res Treat 2011;130:725–34
- Esserman LJ, Berry DA, Cheang MC, . Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657). Breast Cancer Res Treat 2011 Dec 25. Epub ahead of print
- Turaga K, Acs G, Laronga C. Gene expression profiling in breast cancer. Cancer Control 2010;17:177–82
- van de Vijver MJ, He YD, van't Veer LJ, . A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002;347:1999–2009
- Buyse M, Loi S, van't Veer L, . Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer. J Natl Cancer Inst 2006;98:1183–92
- Knauer M, Mook S, Rutgers EJ, . The predictive value of the 70-gene signature for adjuvant chemotherapy in early breast cancer. Breast Cancer Res Treat 2010;120:655–61
- Krijgsman O, Roepman P, Zwart W, . A diagnostic gene profile for molecular subtyping of breast cancer associated with treatment response. Breast Cancer Res Treat 2011 Aug 4. Epub ahead of print
- Kao KJ, Chang KM, Hsu HC, Huang AT. Correlation of microarray-based breast cancer molecular subtypes and clinical outcomes: implications for treatment optimization. BMC Cancer 2011; 11:143
- Fan C, Oh DS, Wessels L, . Concordance among gene-expression based predictors for breast cancer. N Engl J Med 2006;355:560–9
- http://www.biocentury.com/DailyNews/CurrentIssue#43315